ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 130 filers reported holding ENDOLOGIX INC in Q4 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,334,000 | +33.8% | 235,700 | 0.0% | 0.05% | +31.4% |
| Q1 2018 | $997,000 | -20.9% | 235,700 | 0.0% | 0.04% | -10.3% |
| Q4 2017 | $1,261,000 | +20.0% | 235,700 | 0.0% | 0.04% | -11.4% |
| Q3 2017 | $1,051,000 | -8.3% | 235,700 | 0.0% | 0.04% | +158.8% |
| Q2 2017 | $1,146,000 | -32.8% | 235,700 | 0.0% | 0.02% | -37.0% |
| Q1 2017 | $1,706,000 | +26.6% | 235,700 | 0.0% | 0.03% | +12.5% |
| Q4 2016 | $1,348,000 | -55.3% | 235,700 | 0.0% | 0.02% | -54.7% |
| Q3 2016 | $3,017,000 | -42.3% | 235,700 | -43.8% | 0.05% | -34.6% |
| Q2 2016 | $5,226,000 | +198.1% | 419,400 | +100.0% | 0.08% | +179.3% |
| Q1 2016 | $1,753,000 | -15.6% | 209,700 | 0.0% | 0.03% | -9.4% |
| Q4 2015 | $2,076,000 | -19.3% | 209,700 | 0.0% | 0.03% | -27.3% |
| Q3 2015 | $2,571,000 | -20.1% | 209,700 | 0.0% | 0.04% | -6.4% |
| Q2 2015 | $3,217,000 | -10.1% | 209,700 | 0.0% | 0.05% | -13.0% |
| Q1 2015 | $3,580,000 | +17.1% | 209,700 | +4.8% | 0.05% | +17.4% |
| Q4 2014 | $3,058,000 | +60.3% | 200,000 | +11.1% | 0.05% | +64.3% |
| Q3 2014 | $1,908,000 | +56.8% | 180,000 | +125.0% | 0.03% | +55.6% |
| Q2 2014 | $1,217,000 | +89.0% | 80,000 | +60.0% | 0.02% | +80.0% |
| Q1 2014 | $644,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|